Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.
暂无分享，去创建一个
J. Limacher | O. Lantz | E. Piaggio | O. Capitain | E. Jeannot | P. Cassier | J. Delord | A. Lalanne | M. Brandely | S. Salas | F. Rolland | K. Bendjama | G. Marret | C. le Tourneau | A. Tavernaro | Zahra Castel-Ajgal | E. Borcoman | C. Tran‐Perennou | C. Ekwegbara | H. Makhloufi | Joanna Cyrta